Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 06, 2020

SELL
$76.41 - $117.54 $1.05 Million - $1.61 Million
-13,678 Closed
0 $0
Q3 2019

Oct 17, 2019

SELL
$61.52 - $91.1 $343,035 - $507,973
-5,576 Reduced 28.96%
13,678 $1.18 Million
Q2 2019

Jul 25, 2019

SELL
$58.04 - $66.99 $192,750 - $222,473
-3,321 Reduced 14.71%
19,254 $1.25 Million
Q1 2019

May 08, 2019

BUY
$35.52 - $62.62 $801,864 - $1.41 Million
22,575 New
22,575 $1.41 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Cambiar Investors LLC Portfolio

Follow Cambiar Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cambiar Investors LLC with notifications on news.